XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/news/newsmas-this-week-ardena-group-sumitomo-chemical-5936943/20%Daily2017-09-29 17:40
https://www.clinicaltrialsarena.com/news/newsnoxopharm-initiates-phase-ib-trial-nox66-prostate-cancer-5938112/20%Daily2019-08-09 08:40
https://www.clinicaltrialsarena.com/news/newschiasma-begins-enrolment-in-phase-iii-trial-for-acromegaly-5938118/20%Daily2017-09-29 16:52
https://www.clinicaltrialsarena.com/comment/commentorphan-drug-designation-for-argenxs-argx-113hopeful-news-for-myasthenia-gravis-community-5938668/20%Daily2017-09-29 13:59
https://www.clinicaltrialsarena.com/comment/commentfda-approves-first-cancer-biosimilar-but-that-doesnt-mean-it-will-be-available-to-patients-anytime-soon-5938469/20%Daily2017-09-29 13:56
https://www.clinicaltrialsarena.com/comment/commentcarbohydrates-could-be-crucial-to-an-effective-malaria-vaccine-5938462/20%Daily2017-09-29 13:53
https://www.clinicaltrialsarena.com/news/collecting-data-is-the-easy-part-how-to-manage-it-is-the-problem-4799715-2/20%Daily2018-07-18 09:34
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-medicinova-confo-therapeutics-intra-cellular-therapies-5936929/20%Daily2017-09-28 23:00
https://www.clinicaltrialsarena.com/news/newsgenelux-starts-dosing-in-phase-ii-ovarian-cancer-trial-5938102/20%Daily2017-09-28 23:00
https://www.clinicaltrialsarena.com/comment/commentwith-62m-barda-contract-secured-the-future-for-summits-ridinilazole-looks-bright-5937334/20%Daily2017-09-28 13:50
https://www.clinicaltrialsarena.com/comment/abivax-receives-french-regulatory-approval-begin-phase-iia-trial-ulcerative-colitis/20%Daily2017-09-28 13:45
https://www.clinicaltrialsarena.com/news/axovants-phase-iii-trial-alzheimers-disease-drug-fails-meet-primary-endpoints/20%Daily2017-09-28 09:13
https://www.clinicaltrialsarena.com/news/newsbiolinerx-launches-phase-ibii-combination-trial-acute-myeloid-leukaemia-5937189/20%Daily2017-09-28 09:12
https://www.clinicaltrialsarena.com/uncategorized/general-data-protection-regulation-the-impact-on-clinical-trials-and-data-subjects-5937623-2/20%Daily2019-08-08 09:38
https://www.clinicaltrialsarena.com/news/newsaduro-biotech-starts-dosing-in-phase-ib-combination-trial-for-oncology-5937183/20%Daily2017-09-27 23:00
https://www.clinicaltrialsarena.com/marketdata/invasive-meningococcal-disease-changes-serogroups-highlight-importance-vaccination/20%Daily2017-09-27 15:13
https://www.clinicaltrialsarena.com/comment/gsks-shingrix-set-disrupt-herpes-zoster-vaccine-marketplace/20%Daily2017-09-27 15:07
https://www.clinicaltrialsarena.com/news/newsus-uk-researchers-launch-trial-study-treatment-approaches-ms-5936073/20%Daily2017-09-27 08:46
https://www.clinicaltrialsarena.com/news/newsargenx-initiates-phase-ii-trial-argx-113-treat-pemphigus-vulgaris-5935835/20%Daily2017-09-27 08:44
https://www.clinicaltrialsarena.com/news/newsastrazeneca-reports-positive-data-phase-iii-trial-bevespi-aerosphere-5935828/20%Daily2017-09-27 08:02
https://www.clinicaltrialsarena.com/uncategorized/eu-gdpr-maintaining-the-balance-between-big-data-boom-and-patient-confidentiality-5934945-2/20%Daily2019-08-08 09:38
https://www.clinicaltrialsarena.com/comment/kura-oncology-may-hold-hope-mutant-hras-head-neck-cancer-patients/20%Daily2017-09-26 15:04
https://www.clinicaltrialsarena.com/comment/fulfilling-main-unmet-needs-prostate-cancer-will-open-way-new-ones/20%Daily2019-08-09 08:40
https://www.clinicaltrialsarena.com/uncategorized/5-things-to-know-about-gdpr-5934932-2/20%Daily2019-08-08 09:38
https://www.clinicaltrialsarena.com/uncategorized/announcing-gdpr-week-on-clinical-trials-arena-5934919-2/20%Daily2019-08-08 09:38
https://www.clinicaltrialsarena.com/news/prometic-conduct-pbi-4050s-phase-iiiii-trial-ipf-us/20%Daily2017-09-25 23:00
https://www.clinicaltrialsarena.com/news/auris-medical-concludes-enrolment-phase-iii-trial-keyzilen-tinnitus/20%Daily2017-09-25 23:00
https://www.clinicaltrialsarena.com/news/daiichi-sankyo-studies-esaxerenone-phase-iii-trial-diabetic-nephropathy/20%Daily2017-09-25 23:00
https://www.clinicaltrialsarena.com/comment/ucbs-latest-anti-epileptic-drug-advances-epilepsy-market/20%Daily2017-09-25 14:55
https://www.clinicaltrialsarena.com/news/paying-tribute-to-our-pharmacists-5933924-2/20%Daily2018-07-18 11:16
https://www.clinicaltrialsarena.com/news/versartis-phase-iii-trial-somavaratan-fails-meet-endpoint-ghd/20%Daily2017-09-24 23:00
https://www.clinicaltrialsarena.com/news/allergan-reports-positive-phase-iib-two-year-data-liver-fibrosis-trial/20%Daily2017-09-24 23:00
https://www.clinicaltrialsarena.com/news/abbvie-bms-investigate-combination-therapy-solid-tumour-trials/20%Daily2017-09-24 23:00
https://www.clinicaltrialsarena.com/news/digitalizing-the-clinical-supply-chain-a-route-to-patient-centric-trials-5932853-2/20%Daily2018-07-18 11:15
https://www.clinicaltrialsarena.com/news/genae-launches-staicy-5932183-2/20%Daily2018-07-18 11:15
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-nabriva-therapeutics-lifemine-therapeutics-aldeyra-therapeutics-5930760/20%Daily2017-09-21 17:30
https://www.clinicaltrialsarena.com/news/newscavion-starts-enrolment-in-phase-ii-trial-of-cx-8998-for-essential-tremor-5931911/20%Daily2017-09-21 17:30
https://www.clinicaltrialsarena.com/news/newsaudentes-commences-dosing-in-phase-iii-trial-for-myotubular-myopathy-5931919/20%Daily2017-09-21 17:30
https://www.clinicaltrialsarena.com/news/newsshire-reports-positive-data-from-phase-iii-trial-of-intuniv-for-adhd-5932144/20%Daily2017-09-21 17:30
https://www.clinicaltrialsarena.com/news/expert-insight-frequency-of-anti-vegf-injections-remains-a-major-unmet-need-for-the-treatment-of-macular-edema-but-have-developers-lost-sight-of-improved-efficacy-5931794-2/20%Daily2018-07-18 11:14
https://www.clinicaltrialsarena.com/comment/commentnabrivas-first-in-class-antibiotic-lefamulin-aces-key-phase-iii-test-5931155/20%Daily2017-09-21 04:01
https://www.clinicaltrialsarena.com/news/newstransgene-starts-dosing-in-phase-ibii-combination-trial-for-hpv-positive-cancers-5930643/20%Daily2017-09-20 17:30
https://www.clinicaltrialsarena.com/news/newsagenebio-to-study-agb101-in-phase-iii-trial-to-treat-mci-due-to-ad-5930652/20%Daily2017-09-20 17:30
https://www.clinicaltrialsarena.com/news/newsparker-institute-begins-dosing-in-phase-ibii-combination-trial-for-pancreatic-cancer-5930999/20%Daily2017-09-20 17:30
https://www.clinicaltrialsarena.com/news/site-management-in-the-era-of-ich-gcp-e6-r2-5930518-2/20%Daily2018-07-18 11:13
https://www.clinicaltrialsarena.com/news/newsformula-pharma-initiates-phase-iiia-trial-of-allogeneic-cik-cells-for-all-5929899/20%Daily2017-09-19 17:30
https://www.clinicaltrialsarena.com/news/newscytokinetics-begins-dosing-omecamtiv-mecarbil-in-phase-iii-cardiovascular-trial-5929911/20%Daily2019-08-09 08:29
https://www.clinicaltrialsarena.com/news/newsjanssen-reports-positive-long-term-phase-iii-data-of-tremfya-for-plaque-psoriasis-5930047/20%Daily2017-09-19 17:30
https://www.clinicaltrialsarena.com/news/efficient-global-site-selection-new-methodologies-for-selecting-the-right-sites-5929477-2/20%Daily2018-07-18 11:12
https://www.clinicaltrialsarena.com/comment/commentfailure-of-first-lampalizumab-phase-iii-study-could-delay-availability-5928926/20%Daily2017-09-19 04:29
https://www.clinicaltrialsarena.com/comment/commentesmo-2017-pd-l1-as-an-evolving-narrative-in-patient-selection-and-drug-resistance-part-2-5928907/20%Daily2017-09-19 04:22
https://www.clinicaltrialsarena.com/comment/commentesmo-2017-pd-l1-as-an-evolving-narrative-in-patient-selection-and-drug-resistance-part-1-5928867/20%Daily2017-09-19 04:10
https://www.clinicaltrialsarena.com/news/newssanofi-and-regeneron-report-positive-phase-iii-data-from-atopic-dermatitis-trial-5928452/20%Daily2019-08-07 13:57
https://www.clinicaltrialsarena.com/news/newsaustralian-cancer-centres-launch-personalised-medicine-trial-for-childhood-cancers-5928482/20%Daily2017-09-18 17:30
https://www.clinicaltrialsarena.com/news/newsinovio-launches-phase-iiia-trial-for-mers-infection-in-south-korea-5928765/20%Daily2017-09-18 17:30
https://www.clinicaltrialsarena.com/news/newsphrixus-to-study-p-188-nf-in-phase-ii-trial-to-treat-dmd-5927715/20%Daily2017-09-17 17:30
https://www.clinicaltrialsarena.com/news/newsnovo-nordisks-tresiba-minimises-hypoglycaemia-rate-in-diabetes-trial-5927723/20%Daily2019-08-07 13:53
https://www.clinicaltrialsarena.com/news/newstg-therapeutics-commences-enrolment-for-phase-iii-multiple-sclerosis-trials-5927999/20%Daily2017-09-17 17:30
https://www.clinicaltrialsarena.com/comment/commentesmo-2017-adjuvant-opdivo-nivolumab-superior-to-yervoy-ipilimumab-in-surgically-resected-stage-iiiiv-melanoma-5927299/20%Daily2017-09-15 10:05
https://www.clinicaltrialsarena.com/comment/commentesmo-2017-astrazenecas-tagrisso-demonstrates-potential-for-label-expansion-5926887/20%Daily2017-09-15 05:31
https://www.clinicaltrialsarena.com/research-reports/researchreportreport-immuno-oncology-to-evolve-as-a-promising-cancer-treatment-alternative-5923106/20%Daily2017-09-14 17:30
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-synthetic-biologics-bayer-hitgen-5925416/20%Daily2017-09-14 17:30
https://www.clinicaltrialsarena.com/news/newsmas-this-week-invicro-inotek-pharmaceuticals-corporation-5925418/20%Daily2017-09-14 17:30
https://www.clinicaltrialsarena.com/news/newstulane-university-reports-favourable-results-from-new-malaria-trial-5926391/20%Daily2017-09-14 17:30
https://www.clinicaltrialsarena.com/news/newspfizer-and-astellas-report-positive-phase-iii-data-from-prostate-cancer-trial-5926407/20%Daily2017-09-14 17:30
https://www.clinicaltrialsarena.com/news/pharmaceutical-outsourcing-market-ma-and-capital-raisings-part-ii-5925211-2/20%Daily2018-07-18 11:12
https://www.clinicaltrialsarena.com/comment/commentesmo-2017-promising-melanoma-data-for-the-keytruda-plus-epacadostat-combo-resonate-emphatically-5925745/20%Daily2017-09-14 04:24
https://www.clinicaltrialsarena.com/comment/commentesmo-2017-array-biopharmas-encorafenib-plus-binimetinib-combo-highly-effective-5925706/20%Daily2017-09-14 04:13
https://www.clinicaltrialsarena.com/news/newsgsk-reports-positive-phase-iii-results-of-mepolizumab-for-copd-5925613/20%Daily2017-09-13 17:30
https://www.clinicaltrialsarena.com/news/newsmenarini-and-obt-conduct-phase-i-oncology-trial-of-men1309-5925621/20%Daily2017-09-13 17:30
https://www.clinicaltrialsarena.com/news/newsoncomed-begins-dosing-gitrl-fc-in-phase-ia-trial-for-solid-tumours-5925796/20%Daily2017-09-13 17:30
https://www.clinicaltrialsarena.com/news/expert-insights-alkermes-staying-positive-over-depression-drug-5925209-2/20%Daily2018-07-18 11:11
https://www.clinicaltrialsarena.com/marketdata/researchreportosteoarthritis-is-significantly-underdiagnosed-in-the-us-5924594/20%Daily2017-09-13 04:02
https://www.clinicaltrialsarena.com/news/newsdiamedica-begins-phase-ii-trial-to-treat-acute-ischemic-stroke-5924477/20%Daily2017-09-12 17:30
https://www.clinicaltrialsarena.com/news/newsucla-starts-phase-i-stem-cell-trial-for-cancers-with-ny-eso-1-marker-5924494/20%Daily2017-09-12 17:30
https://www.clinicaltrialsarena.com/news/newszafgen-studies-zgn-1061-in-phase-ii-trial-for-type-2-diabetes-5924764/20%Daily2017-09-12 17:30
https://www.clinicaltrialsarena.com/news/esource-data-integration-5924054-2/20%Daily2018-07-18 11:10
https://www.clinicaltrialsarena.com/news/newsresearchers-report-positive-results-from-two-melanoma-trials-in-australia-5923430/20%Daily2017-09-11 17:30
https://www.clinicaltrialsarena.com/news/newsrealm-therapeutics-to-initiate-phase-ii-trial-for-allergic-conjunctivitis-5923440/20%Daily2017-09-11 17:30
https://www.clinicaltrialsarena.com/news/newseisai-reports-positive-data-from-phase-ibii-study-of-lenvatinib-for-rcc-5923482/20%Daily2017-09-11 17:30
https://www.clinicaltrialsarena.com/news/newsboehringer-launches-phase-iia-trial-for-diabetic-retinopathy-5922208/20%Daily2017-09-10 17:30
https://www.clinicaltrialsarena.com/news/newseisai-and-ono-pharma-to-conduct-phase-ib-combination-trial-for-liver-cancer-5922218/20%Daily2017-09-10 17:30
https://www.clinicaltrialsarena.com/news/newsleap-therapeutics-eortc-to-initiate-combination-trial-of-oncology-drugs-5922227/20%Daily2017-09-10 17:30
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-sanofi-entasis-therapeutics-inc-helsinn-therapeutics-us-inc-5919937/20%Daily2017-09-07 17:30
https://www.clinicaltrialsarena.com/news/newsverastem-improves-progression-free-survival-in-phase-iii-trial-for-cll-and-sll-5920843/20%Daily2017-09-07 17:30
https://www.clinicaltrialsarena.com/news/newsbms-phase-iii-combination-trial-for-renal-cell-carcinoma-meets-endpoints-5920861/20%Daily2017-09-07 17:30
https://www.clinicaltrialsarena.com/news/newscaris-studies-show-use-of-molecular-profiling-to-develop-oncology-therapies-5920985/20%Daily2017-09-07 17:30
https://www.clinicaltrialsarena.com/marketdata/featureaugust-2017-top-news-stories-drug-5910400/20%Daily2017-09-07 09:32
https://www.clinicaltrialsarena.com/marketdata/researchreportimmuno-oncology-drugs-lead-japanese-clinical-trials-2012-2016-5920379/20%Daily2017-09-07 08:46
https://www.clinicaltrialsarena.com/news/pharmaceutical-outsourcing-market-ma-and-capital-raisings-part-i-5920014-2/20%Daily2021-10-31 15:02
https://www.clinicaltrialsarena.com/news/newsaelix-commences-enrolment-in-phase-i-trial-for-hiv-vaccine-5919698/20%Daily2017-09-06 17:30
https://www.clinicaltrialsarena.com/news/newsaeglea-begins-dosing-in-phase-iii-trial-of-aeb1102-for-arginase-1-deficiency-5919712/20%Daily2017-09-06 17:30
https://www.clinicaltrialsarena.com/news/newsamgen-and-astrazeneca-report-positive-results-of-phase-iib-asthma-trial-5919916/20%Daily2017-09-06 17:30
https://www.clinicaltrialsarena.com/news/perils-and-pitfalls-when-dealing-with-an-assay-dependent-clinical-trial-5919195-2/20%Daily2018-07-18 11:07
https://www.clinicaltrialsarena.com/news/newsfaron-receives-idmc-recommendation-to-continue-phase-iii-ards-trial-5918103/20%Daily2017-09-05 17:30
https://www.clinicaltrialsarena.com/news/newsh3-biomedicine-initiates-dosing-in-phase-i-trial-of-breast-cancer-drug-5918112/20%Daily2017-09-05 17:30
https://www.clinicaltrialsarena.com/news/newsbials-epilepsy-drug-shows-clinical-efficacy-in-real-world-study-5918818/20%Daily2017-09-05 17:30
https://www.clinicaltrialsarena.com/marketdata/researchreportpah-registries-may-underestimate-patient-size-by-as-much-as-sevenfold-5917949/20%Daily2017-09-05 10:17
https://www.clinicaltrialsarena.com/news/industry-viewpoints-overseeing-the-use-of-third-party-technology-5917666-2/20%Daily2018-07-18 11:06
https://www.clinicaltrialsarena.com/news/newseisai-to-highlight-data-from-lenvatinib-trials-for-uhcc-and-rcc-5917173/20%Daily2017-09-04 17:30
https://www.clinicaltrialsarena.com/news/newsmidatech-files-cta-for-mtd201s-carcinoid-cancer-and-acromegaly-trial-5917178/20%Daily2017-09-04 17:30
https://www.clinicaltrialsarena.com/news/newsfda-initiates-clinical-hold-on-cellectis-ucart123-trials-5917720/20%Daily2017-09-04 17:30
https://www.clinicaltrialsarena.com/news/the-top-5-august-2017-5916431-2/20%Daily2018-07-18 11:06
https://www.clinicaltrialsarena.com/news/newsheptares-starts-dosing-in-phase-i-trial-of-alzheimers-drug-5916390/20%Daily2017-09-03 17:30
https://www.clinicaltrialsarena.com/news/newsoncbiomune-to-investigate-new-prostate-cancer-drug-in-phase-ii-trial-5916397/20%Daily2017-09-03 17:30
https://www.clinicaltrialsarena.com/news/newsastrazeneca-to-report-data-from-multiple-oncology-trials-at-esmo-2017-5916586/20%Daily2017-09-03 17:30
https://www.clinicaltrialsarena.com/news/exploring-the-possibilities-of-leveraging-clinical-trial-analytics-to-improve-outcomes-5909334-2/20%Daily2018-07-18 11:04
https://www.clinicaltrialsarena.com/comment/commentesc-congress-barcelona-2017-highlights-when-should-triple-combination-regimens-be-prescribed-for-pah-patients-5915447/20%Daily2017-09-01 04:56
https://www.clinicaltrialsarena.com/comment/commentesc-congress-barcelona-2017-highlights-is-ralinepag-superior-to-current-pah-treatments-5915404/20%Daily2017-09-01 04:42